How often does Vericel move more than the options market prices?

1 of the last 7 reports moved at least as far as the implied move.

VCELNasdaqBiological Products, (No Diagnostic Substances)

Vericel Corp (VCEL) earnings date, market-implied expected move, and options open interest by expiry

54.46

+2.68 · +5.18%

post 54.45 −0.02%

After hours16:00 ET

Open52.00Volume2.7MMkt cap$2.6BP/E81.27EPS0.67

Day51.41 – 54.46100%52-wk28.95 – 55.6096%

VCEL

Vericel Corp

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 25

before open · in 111 days

est.Q4 FY26

Calendar

Next report

Last report

+13.85%

shaded = implied · ▲▼ = realized

Nov 5 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+2.03%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

318 managers

Top fund weight

0.49%

VCEL weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Vericel (VCEL) is expected to report on Feb 25 before open (estimated date).

Implied vs realized

8 reports

1 of 7≥ implied

avg implied: ±12.6%
avg realized: ±4.5%

May 8 '25May 8 '25confirmed±10.8%▲+3.46%×0.32

Jul 31 '25Jul 31 '25confirmed±11.6%▼−14.07%×1.22

Nov 6 '25Nov 6 '25confirmed±15.6%▲+4.17%×0.27

Jan 13 '26Jan 13 '26confirmed±12.9%▲+1.26%×0.10

Q1 FY26Feb 26 '26confirmed±14.8%▲+1.59%×0.11

May 7 '26May 7 '26confirmed±9.1%▼−4.49%×0.49

Q2 FY26Jul 30 '26confirmed±13.2%▲+2.12%×0.16

Q3 FY26Nov 5 '26confirmed—▲+13.85%—

quarterimplied−20%0+20%realized×

Q3 FY26—▲+13.85%—

Q2 FY26±13.2%▲+2.12%×0.16

May '26±9.1%▼−4.49%×0.49

Q1 FY26±14.8%▲+1.59%×0.11

Jan '26±12.9%▲+1.26%×0.10

Nov '25±15.6%▲+4.17%×0.27

2 older reports

Jul '25±11.6%▼−14.07%×1.22

May '25±10.8%▲+3.46%×0.32

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 1 expiry · Nov 4 close

1.20OI · 1 expiry · Nov 4 closeP/C open interest · Jan 15 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1470%Jan 1570d123+7%

ExpiryPutsCallsP/C

Jan 1570d1470%123+7%1.20

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

16.59%as filednet margin · revenue +10.22% QoQ · +26.47% YoY

Revenue$85M+10.22%

Gross profit$63M73.34%+11.01%

Operating income$12M14.27%+2707.83%

Pre-tax income$14M+541.93%

Net income$14M16.59%+541.93%

Cost of revenue$23M+8.10%

Operating expenses$50M−9.91%

Other income$2M+11.46%

Source: SEC filings · standardized · QE Sep 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.19· ±2.6% vs ±2.2% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±2.6%12 of 24×1.19

NFPjobs report±2.5%4 of 10×1.16

PCEpersonal income & outlays±2.5%9 of 19×1.14

PPIproducer prices±1.8%4 of 10×0.84

GDPgross domestic product±1.8%8 of 19×0.81

CPIconsumer prices±1.6%7 of 10×0.72

CPROFcorporate profits±1.3%3 of 12×0.59

Bar = avg |move| to ±3% · tick = ±2.2% avg day · ×base = |move| ÷ ±2.2% · min 6 releases

Earnings history

EPS 0.27 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 5 '26 · confirmed	0.27	—
Q2 FY26	Jul 30 '26 · confirmed	0.04	—
Q1 FY26	Feb 26 '26 · confirmed	-0.12	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod